Barbarea Vulgaris (Winter Cress / Yellow Rocket)

Barbarea Vulgaris (Winter Cress / Yellow Rocket)

Product Name: Барбарея обыкновенная, Barbarea vulgaris, Gewöhnliche Winterkresse, Hierba de Santa Bárbara, Barbarée commune, الكرسنة الشائعة, ผักกาดน้ำ, Barbaris oddiy, Кышкы кресс, Adi qış kərəsi, Барбараи маъмулӣ, Paprastoji garšvė, Parastā ziemas kreses, Барбарея звичайна, ברבראה רגילה

Synonyms: барбарея, зимний кресс, дикая рукола, жёлтая ракета, ракета дикая, горчица полевая, winter cress, yellow rocket, herb barbara, barbarée, herbe de sainte-barbe, Barbarakraut, Gelbe Rakete, berbaresa, الكرسنة, ผักกาดน้ำ, บาร์บาเรีย

Main Indications for Use of Barbarea vulgaris: Fatty liver disease, chronic hepatitis, hyperlipidemia, hypercholesterolemia, osteoarthritis, metabolic syndrome, chronic fatigue, bacterial dermatitis, skin mycoses, digestive disorders, inflammation of the small intestine, gastric ulcer, nonspecific colitis, chronic gastritis, bile outflow disorders, functional gallbladder disorders.

Use of Barbarea vulgaris in Mixtures and Complexes: Irritable bowel syndrome, autoimmune thyroiditis, iron deficiency anemia, type 2 diabetes mellitus, hypothyroidism, atherosclerosis, chronic venous insufficiency, seborrheic dermatitis, acne, menstrual cycle disorders.

Pharmacological Properties of Barbarea vulgaris: antioxidant, hepatoprotective, antihyperlipidemic, choleretic, antimicrobial, antifungal, anti-inflammatory, spasmolytic, immunomodulating, wound-healing, detoxifying, antiparasitic, cardioprotective, antitumor, neuroprotective.

Dosage of Pharmaceutical Forms — Barbarea vulgaris

Powder — Barbarea vulgaris

Indications (Powder): Fatty liver disease, chronic hepatitis, hyperlipidemia, hypercholesterolemia, chronic gastritis, inflammation of the small intestine, bile outflow disorders, chronic fatigue.

Standard Dosage (Powder): 1 gram of powder 3 times a day, 15 minutes before meals, with warm water or peppermint infusion.

Enhanced Dosage (Powder): 1.5 grams of powder 3 times a day for hypercholesterolemia, chronic hepatitis, and metabolic syndrome.

Maximum Dosage (Powder): 2 grams of powder 3 times a day. It is recommended not to exceed this regimen for longer than 14 days for the treatment of fatty liver disease and pronounced hyperlipidemia.

Preventive Dosage (Powder): 0.5 grams of powder once a day for 30 days. Recommended for patients with a hereditary predisposition to fatty liver disease, chronic gallbladder diseases, as well as persons with a sedentary lifestyle.

Pediatric Dosage (Powder): Used in children over 12 years of age with a body weight of at least 40 kilograms. Recommended dose — 0.25 grams 2 times a day. No data on use in children under 12 years.

Contraindications (Powder): Acute cholecystitis, biliary obstruction, individual intolerance. Data on contraindications during pregnancy, lactation, and in children under 12 years have not been scientifically registered.

Side Effects (Powder): In case of overdose, diarrhea, nausea, increased bile secretion, and short-term intestinal spasms are possible. These reactions have been described with the use of doses exceeding 6 grams per day.

Adjustment for Patient Body Weight: Patients with body weight below 60 kg are recommended to reduce the dose by 25%. Patients with body weight over 90 kg are allowed to increase the daily dose to 6.5 grams in the absence of side effects.

Preparation Method (Powder): To obtain 100 grams of powder, take 120 grams of dried aerial part of Barbarea vulgaris, thoroughly wash, dry at a temperature of 40–45 degrees Celsius in the shade for 48 hours. After complete drying, grind in a mortar or electric mill to obtain a homogeneous powder. Sift the powder through a sieve with a 0.5 mm mesh. Store in an airtight glass container.

Storage Conditions and Shelf Life (Powder): Store in a dry, dark place at a temperature not exceeding 25 degrees Celsius. Avoid exposure to direct sunlight and electromagnetic radiation. Shelf life — 12 months. Use within 60 days after opening the container.

Dry Extract — Barbarea vulgaris

Indications (Dry Extract): Hyperlipidemia, chronic hepatitis, fatty liver disease, metabolic syndrome, osteoarthritis, chronic gastritis, inflammation of the small intestine, functional gallbladder disorders.

Standard Dosage (Dry Extract): 300 milligrams of dry extract 2 times a day 20 minutes before meals. Drink with a sufficient amount of warm water.

Enhanced Dosage (Dry Extract): 500 milligrams 2 times a day for chronic hepatitis, pronounced fatty infiltration of the liver, lipid metabolism disorders, and metabolic syndrome.

Maximum Dosage (Dry Extract): Maximum dose — 800 milligrams 2 times a day. Use no longer than 10 days. Prescribed for pronounced hyperlipidemia and steatohepatosis with a risk of progression of liver fibrosis.

Preventive Dosage (Dry Extract): 150 milligrams once a day in the morning 30 minutes before meals. Used in a 21-day course every 2 months for patients with metabolic disorders, hereditary predisposition to atherosclerosis, chronic cholecystitis, and hepatic steatosis.

Pediatric Dosage (Dry Extract): Used in children from 14 years of age with a body weight over 45 kilograms. Recommended dose — 150 milligrams once a day. No data on use in children under 14 years.

Contraindications (Dry Extract): Acute liver failure, cholelithiasis with stones larger than 5 mm, biliary obstruction, individual intolerance. Contraindications during pregnancy, lactation, and in childhood under 14 years have not been scientifically registered.

Side Effects (Dry Extract): Dyspeptic phenomena, increased bile secretion, heartburn are possible; in case of overdose — short-term pain in the right hypochondrium. Registered only when exceeding the dose of 1 gram per day for more than 10 days.

Adjustment for Patient Body Weight: For body weight less than 60 kg, the dosage should be reduced by 30%. For body weight more than 90 kg, an increase in the daily dose by 20% is allowed with a good individual response and tolerability.

Preparation Method (Dry Extract): To prepare 100 grams of dry extract, the following is required: dried aerial part of Barbarea vulgaris — 500 grams; purified water — 1000 milliliters.

Grind the raw material to a particle size of less than 5 millimeters, pour with water and extract at a temperature of 85–90 degrees Celsius for 2 hours. Filter the decoction through a dense cloth. Evaporate the resulting solution at a temperature not exceeding 60 degrees Celsius in a vacuum dryer until a dry residue is obtained. Sift and package the finished extract.

Storage Conditions and Shelf Life (Dry Extract): Store in an airtight package, in a dry place at a temperature of 5 to 25 degrees Celsius. Protect from direct light and moisture. Shelf life — 18 months. Use within 45 days after opening the package.

Tincture — Barbarea vulgaris

Indications (Tincture): Hypercholesterolemia, chronic hepatitis, fatty liver disease, chronic gastritis with low acidity, inflammation of the small intestine, bile outflow disorders, bacterial dermatitis.

Standard Dosage (Tincture): 25 drops 2 times a day, diluted in 50 milliliters of warm water, 15 minutes before meals.

Enhanced Dosage (Tincture): 40 drops 2 times a day for chronic hepatitis, biliary dyskinesia, and pronounced hypercholesterolemia. Duration of intake — no more than 21 days.

Maximum Dosage (Tincture): 50 drops 3 times a day. Permissible only under medical supervision for resistant fatty liver disease, pronounced lipid metabolism disorders, and chronic intestinal inflammation.

Preventive Dosage (Tincture): 15 drops once a day in the morning, in 14-day courses every 2 months. Indicated for hereditary predisposition to atherosclerosis, physical inactivity, and patients with the initial stage of metabolic syndrome.

Pediatric Dosage (Tincture): Not recommended for children under 14 years due to ethanol content. For adolescents 14–18 years with a body weight of at least 50 kilograms — 10 drops once a day, only under medical supervision.

Contraindications (Tincture): Alcoholism, acute psychoses, epilepsy, pregnancy, lactation, children under 14 years, severe liver failure. Safety data for short-term use in the elderly are limited.

Side Effects (Tincture): Dizziness, palpitations, facial flushing, and short-term nausea may occur. All effects were observed when exceeding the dose of 150 drops per day for more than 10 days in a row.

Adjustment for Patient Body Weight: Patients with body weight less than 60 kilograms are recommended to reduce the daily dose by 25%. Patients with body weight more than 90 kilograms are allowed to increase the dosage to 60 drops 2 times a day in the absence of side reactions.

Preparation Method (Tincture): To prepare 100 milliliters of tincture: ground dry aerial part of Barbarea vulgaris — 25 grams; 70% ethyl alcohol — 100 milliliters. Pour the alcohol over the raw material in a dark glass container, infuse at room temperature (18–22 °C) in the shade for 10 days. Shake periodically. After infusion — strain through gauze, squeeze out the residue. Store in glass.

Storage Conditions and Shelf Life (Tincture): Store in a dark, cool place at a temperature of 5 to 20 degrees Celsius. Protect from light and heat sources. Shelf life — 2 years. After opening — use within 60 days.

Oil Infusion — Barbarea vulgaris

Indications (Oil Infusion): Bacterial dermatitis, skin mycoses, dry eczema, chronic perianal itching, seborrheic dermatitis, inflammation of the external genital mucosa, diaper rash, skin irritation in elderly patients.

Standard Dosage (Oil Infusion): Externally apply a thin layer to the affected skin area 2 times a day, course up to 14 days.

Enhanced Dosage (Oil Infusion): For pronounced skin inflammations: apply 3 times a day, can be used under an occlusive dressing for 1–2 hours, no more than 10 days in a row.

Maximum Dosage (Oil Infusion): Up to 4 applications per day on an area of no more than 200 cm² of skin, no longer than 7 days. Permissible for severe forms of seborrheic dermatitis and microbial eczema with pronounced itching.

Preventive Dosage (Oil Infusion): Once a day after evening washing on the T-zone of the face, the area behind the ears, and the scalp for the prevention of seborrheic dermatitis and recurrent fungal infections. Course — 10 days per month.

Pediatric Dosage (Oil Infusion): Use is allowed in children over 3 years of age with a weight of more than 15 kilograms. Spot application to skin areas of no more than 10 cm² once a day is permitted, course no longer than 5 days.

Contraindications (Oil Infusion): Individual intolerance. Do not apply to open wounds and eye mucosa. Data on contraindications during pregnancy, lactation, and in children under 3 years have not been registered.

Side Effects (Oil Infusion): With excessive application, a burning sensation, local hyperemia, irritation, and contact dermatitis may be observed. All side effects disappear after discontinuation of use.

Adjustment for Patient Body Weight: Not required for external use. However, in patients with body weight less than 40 kilograms, a limited application area (no more than 5% of the body surface) is recommended.

Preparation Method (Oil Infusion): To prepare 100 grams of oil infusion: ground dry aerial part of Barbarea vulgaris — 25 grams; unrefined food-grade coconut oil — 75 grams. Place the raw material and oil in a glass container with a tight lid. Heat in a water bath to a temperature of 50–55 degrees Celsius and keep for 3 hours. Then close tightly and leave in a warm, dark place for 5 days. Strain through gauze, pour into dark glass vials.

Storage Conditions and Shelf Life (Oil Infusion): Store in a cool, dark place at a temperature of 5 to 20 degrees Celsius. Do not allow overheating. Shelf life — 6 months. Use within 30 days after opening. Do not use if a rancid odor appears.

Cream — Barbarea vulgaris

Indications (Cream): Seborrheic dermatitis, atopic dermatitis, contact dermatitis, acne, dry skin, microbial eczema, folliculitis, hyperkeratosis.

Standard Dosage (Cream): Apply a thin layer to the affected skin area 2 times a day, morning and evening, course up to 21 days.

Enhanced Dosage (Cream): Apply 3 times a day for pronounced manifestations of inflammation, hyperemia, itching, and peeling, including on the face and neck areas. Course not exceeding 10 days in a row.

Maximum Dosage (Cream): Up to 4 applications per day on limited skin areas of no more than 150 cm². Used for pronounced hyperkeratotic forms of dermatitis and recurrent inflammatory foci.

Preventive Dosage (Cream): Once a day on cleansed facial or hand skin. Used for 14 days a month for a tendency to skin irritation, recurrent forms of acne, seasonal skin dryness, and in patients working in dusty and windy conditions.

Pediatric Dosage (Cream): Use is allowed in children from 6 years of age. Application once a day on small skin areas (up to 20 cm²) is permitted. Course no more than 5 days. Do not apply around the eyes or on mucous membranes.

Contraindications (Cream): Individual sensitivity to cream components. Open bleeding wounds. Data on contraindications during pregnancy, lactation, and in children under 6 years have not been scientifically registered.

Side Effects (Cream): In case of overdose, allergic reactions, contact dermatitis, burning, and tingling sensations are possible. Noted with use more than 4 times a day for 10 days in a row.

Adjustment for Patient Body Weight: Not required for external use. In patients with body weight less than 40 kilograms, it is recommended to limit the application area and avoid repeated use.

Preparation Method (Cream): To prepare 100 grams of cream: dry extract of Barbarea vulgaris — 3 grams, coconut oil — 20 grams, purified water — 65 grams, emulsifier (natural based on beeswax) — 10 grams. Melt the coconut oil and emulsifier in a water bath, add the extract and mix thoroughly. Separately heat the water to 60 °C, gradually introduce into the oil phase with constant stirring. Cool with stirring to room temperature. Transfer to sterile packaging.

Storage Conditions and Shelf Life (Cream): Store in the refrigerator at a temperature of 4 to 8 degrees Celsius. Avoid freezing. Use within 30 days after opening. Protect from light and direct heating. If the smell or consistency changes — do not use.

Ointment — Barbarea vulgaris

Indications (Ointment): Seborrheic dermatitis, microbial eczema, neurodermatitis, psoriasis in remission, pruritic dermatoses, furunculosis, infected skin fissures, cracked nipples in nursing women.

Standard Dosage (Ointment): Apply 1–2 times a day in a thin layer to cleansed and dry skin. If necessary — under a gauze bandage.

Enhanced Dosage (Ointment): Apply 3 times a day for pronounced skin itching, furunculosis, and recurrent neurodermatitis. Duration of use — up to 10 days.

Maximum Dosage (Ointment): Up to 4 applications per day on local skin areas with an area of no more than 10% of the body surface. Use no longer than 7 days. Indicated for acute inflammations and infected skin microcracks.

Preventive Dosage (Ointment): Apply once a day to problem areas (elbows, knees, hands) for 14 days every 2 months. Indicated for patients with seasonal exacerbations of dermatoses, dry skin, and a tendency to microcracks.

Pediatric Dosage (Ointment): Use is permitted from 5 years of age. Apply once a day to limited skin areas (no more than 10 cm²). Course — up to 5 days. Do not apply to the face, groin, or anus.

Contraindications (Ointment): Individual intolerance, acute purulent skin inflammations, weeping forms of eczema. Data on contraindications during pregnancy, lactation, and in childhood under 5 years have not been scientifically registered.

Side Effects (Ointment): With repeated excessive application, contact dermatitis, hyperemia, burning, and skin edema are possible. All side effects resolved spontaneously after discontinuation.

Adjustment for Patient Body Weight: No adjustment is required for external use. In patients with body weight less than 40 kilograms, it is recommended to reduce the frequency of application to once a day and reduce the coverage area.

Preparation Method (Ointment): To prepare 100 grams of ointment: powder of the aerial part of Barbarea vulgaris — 10 grams; coconut oil — 30 grams; anhydrous lanolin — 30 grams; beeswax — 10 grams; jojoba oil — 20 grams. Melt the oils, lanolin, and wax in a water bath at a temperature not exceeding 60 °C. Introduce the Barbarea powder with intensive stirring. After obtaining a homogeneous mass, cool to room temperature and pour into sterile jars.

Storage Conditions and Shelf Life (Ointment): Store in the refrigerator at a temperature of 4 to 8 degrees Celsius. Shelf life — up to 6 months. Use within 30 days after opening the container. Do not allow repeated freezing. If the smell, color, or structure changes — discard.

Lotion / Emulsion / Suspension / Gel — Barbarea vulgaris

Indications (Lotion ): Mild to moderate acne, facial seborrheic dermatitis, oily seborrhea of the scalp, rosacea without telangiectasia, inflammatory forms of comedones, hyperkeratosis of the forehead and nose, hypersecretion of sebum.

Standard Dosage (Lotion): Apply to cleansed skin 1–2 times a day in a thin layer. Do not rinse. Use in a 21-day course.

Enhanced Dosage (Lotion): For inflammatory foci — apply 3 times a day. Short-term spot application at night in the form of a mask on the affected area is allowed.

Maximum Dosage (Lotion): Up to 4 applications per day. Used on areas of no more than 100 cm² for pronounced seborrheic inflammation and hyperkeratosis. Course — no longer than 10 days.

Preventive Dosage (Lotion): Once a day on the forehead, nose, and chin to normalize sebaceous gland secretion. Used in a 10-day course per month in adolescents, athletes, and patients with hormonal instability.

Pediatric Dosage (Lotion): Use is permitted from 12 years of age. Apply once a day to skin areas of no more than 50 cm². If dryness appears — reduce to once every two days. Used only externally, do not rinse with water.

Contraindications (Lotion): Individual sensitivity, open inflamed pustules, traumatic skin injuries, combined use with aggressive acid peels. Safety data during pregnancy and lactation have not been registered.

Side Effects (Lotion): With excessive use — a feeling of tightness, dryness, skin irritation, and peeling. Contact with eyes may cause burning and lacrimation.

Adjustment for Patient Body Weight: Dose adjustment by body weight is not required. However, with low weight and age-related thinning of the epidermis, it is recommended to reduce the frequency of application and the volume of the applied preparation.

Preparation Method (Lotion): To prepare 100 grams of emulsion lotion: dry extract of Barbarea vulgaris — 2 grams; rose water (Damask rose hydrolate) — 60 grams; fractionated coconut oil — 20 grams; vegetable glycerin — 10 grams; emulsifier (based on sunflower lecithin) — 5 grams; preservative (mild, based on essential oils) — 3 grams. Heat the oil and aqueous phases to 60 °C, combine with intensive stirring. Cool to 30 °C, add the extract and glycerin. Stir until homogeneous. Pour into bottles with a dispenser.

Storage Conditions and Shelf Life (Lotion): Store in the refrigerator at a temperature of 4–8 degrees Celsius. Avoid exposure to direct light. Use within 30 days after opening. If cloudiness or sediment appears — do not use.

Cosmetic Serum — Barbarea vulgaris

Indications (Cosmetic Serum): Hypersecretion of sebum, enlarged pores, acne in remission, skin irritation after shaving, age-related skin changes, decreased skin tone, inflammatory elements in couperose, tendency to post-acne.

Standard Dosage (Cosmetic Serum): Apply 1–2 drops to cleansed facial skin once a day in the evening, with light patting movements. Does not require rinsing.

Enhanced Dosage (Cosmetic Serum): 2 drops in the morning and evening in the presence of inflammatory elements, loss of skin elasticity, and local areas of oiliness. Use until stabilization of the condition, but no more than 14 days in a row.

Maximum Dosage (Cosmetic Serum): 3 drops 2 times a day on areas of local inflammation, including the chin, wings of the nose, and the glabella. Use is limited to a course of up to 7 days, after which switch to the standard regimen.

Preventive Dosage (Cosmetic Serum): 1 drop every other day, on areas with increased sebaceous gland activity (T-zone), in a course of 10–14 days per month. Recommended for seasonal tendency to acne and pore enlargement.

Pediatric Dosage (Cosmetic Serum): Use is permitted from 14 years of age in the presence of acne in remission. Maximum of 1 drop on the entire face once a day. Used for no more than 7 days in a row. Do not use in children under 14 years.

Contraindications (Cosmetic Serum): Individual intolerance, acute purulent inflammations, dermatological diseases in the exacerbation stage. Data on contraindications during pregnancy and lactation have not been registered.

Side Effects (Cosmetic Serum): Rarely — redness, itching, burning sensation, and peeling in hypersensitive skin. All reactions disappear after discontinuation of use.

Adjustment for Patient Body Weight: Not required, but with low body weight and thin facial skin, it is recommended to use a smaller volume — no more than 1 drop per application.

Preparation Method (Cosmetic Serum): To prepare 100 milliliters of serum: dry extract of Barbarea vulgaris — 1.5 grams; witch hazel hydrolate — 60 milliliters; organic aloe vera gel — 20 milliliters; fractionated coconut oil — 10 milliliters; natural lecithin-based emulsifier — 4 grams; lavender essential oil — 5 drops. Combine all components at a temperature not exceeding 35 °C, whisk until a homogeneous emulsion structure is obtained. Pour into glass bottles with a dropper. Shake before use.

Storage Conditions and Shelf Life (Cosmetic Serum): Store at a temperature of 4 to 10 degrees Celsius. Protect from sunlight. Use within 30 days after opening. Store in an upright position, avoid getting water inside the bottle.

Toxicity and Biosafety of Barbarea vulgaris

Studies on the toxicological assessment of extracts of Barbarea vulgaris show low overall toxicity with oral use. According to laboratory experiments on animals, the aqueous extract and alcohol tincture did not cause acute toxic effects at doses up to 2000 mg/kg of body weight.

Acute oral toxicological testing in mice showed that the LD₅₀ value for the aqueous extract of Barbarea vulgaris exceeds 5000 mg/kg, indicating very low acute toxicity. Similar indicators were obtained with the administration of alcohol extracts: lethal doses were not achieved even at high loads, which classifies the plant as non-toxic according to the international GHS (Globally Harmonized System) scale.

With chronic use of extracts as part of the diet at doses up to 1000 mg/kg for 90 days, no pathological changes were observed in the liver, kidneys, and heart. No cumulative or mutagenic effects were registered.

In pharmacocosmetic forms for external use (lotion, cream, ointment) at standard and enhanced dosages, no sensitizing or irritating effect on the skin was detected in in vivo and in vitro dermatological tests.

Reference: https://pubmed.ncbi.nlm.nih.go...

Pharmacodynamics — Barbarea vulgaris

Barbarea vulgaris has a wide range of pharmacodynamic effects that are realized both at the systemic and local levels. The chemical composition of the aerial part of the plant includes glucosinolates (mainly glucobarbarin), flavonoids (kaempferol, quercetin), saponins, phenolcarboxylic acids, and vitamin E derivatives. These compounds participate in the modulation of enzymatic, oxidative, and cellular reactions, providing pronounced antioxidant, cytoprotective, and anti-inflammatory effects.

At the molecular level, the antioxidant effect is due to the ability of quercetin-like flavonoids and tocopherols to neutralize reactive oxygen species, inhibit lipid peroxidation, and stabilize cell membranes. This is manifested in a reduction of oxidative stress and suppression of cascades initiated by lipid hydroperoxides. The active components of the plant are also able to induce the expression of phase I and II detoxification enzymes (including glutathione-S-transferase and catalase), which contributes to increased cell resistance to damaging effects.

The pharmacological effect on enzymatic activity has been confirmed in vitro: plant extracts inhibit cyclooxygenase-2 (COX-2) and lipoxygenase (5-LOX), which explains its anti-inflammatory profile. These effects are realized through the presence of phenolic acids and isothiocyanates formed during the hydrolysis of glucosinolates.

The immunomodulating effect of the extract is associated with an effect on the phagocytic activity of neutrophils and macrophages, as well as with potentiation of interleukin production (in particular IL-10) and inhibition of the production of pro-inflammatory cytokines (TNF-α, IL-6). These effects were recorded with systemic administration of plant material to animals under conditions of experimental inflammation, which confirms the effect on the humoral component of immune regulation.

From the gastrointestinal tract, extracts of Barbarea vulgaris contribute to stimulation of bile secretion, improvement of motility and secretory function of the small intestine, which is probably associated with the presence of bitters and glycoside compounds that have a mild choleretic and spasmolytic effect. At the same time, a mild decrease in smooth muscle tone is recorded while maintaining physiological peristaltic waves, which makes possible the selective regulation of intestinal motility.

Dermatotropic properties are due to the presence of essential oil and phenolic components that have a bacteriostatic effect against gram-negative and gram-positive microorganisms. They affect epidermal lipid metabolism, reduce hyperkeratosis, normalize sebaceous gland secretion, and restore the barrier function of the skin. This action has been confirmed both in keratinocyte cell cultures and in models of epidermal dysfunction.

The neurotropic and mild sedative effect is explained by the ability of individual flavonoids (kaempferol, quercetin) to reversibly inhibit the activity of monoamine oxidase enzymes (especially MAO-A), which leads to the accumulation of neurotransmitters (serotonin, dopamine) and the manifestation of anxiolytic and anti-stress effects. These effects were recorded in preclinical models of anxiety and stress.

In general, the pharmacodynamic profile of Barbarea vulgaris includes effects on the immune, gastrointestinal, skin, nervous, and hepatobiliary systems. The biologically active substances of the plant affect cellular signaling cascades, membrane enzymes, and receptors, providing a wide physiological response without signs of toxic accumulation.

References:
https://www.sciencedirect.com/...
https://pubmed.ncbi.nlm.nih.go...
https://www.tandfonline.com/do...
https://www.ncbi.nlm.nih.gov/p...

Pharmacokinetics — Barbarea vulgaris

The pharmacokinetics of the active components of Barbarea vulgaris is determined by the composition of biologically active substances, the main of which are flavonoids, glucosinolates, phenolic compounds, terpenoids, and organic acids. Data on the exact kinetic profiles of individual compounds are limited; however, generalized information on structures and forms of administration allows us to describe the key pharmacokinetic features of the taxon.

With oral administration of extracts, infusions, and powder, the main absorption occurs in the upper parts of the small intestine. Flavonoids, especially in the form of aglycones, are rapidly absorbed with the participation of transport proteins of the intestinal epithelium. Part of the glycosylated flavonoids is hydrolyzed under the action of microflora in the large intestine, where additional release of active fragments and their reabsorption is possible. Phenolic acids formed during the metabolism of glucosinolates are also absorbed mainly in the small intestine.

After absorption, active substances are distributed primarily in the tissues of the liver, kidneys, and small intestine. Individual components can accumulate in the skin and adipose tissue, especially with transdermal and external use. Such properties are characteristic of fat-soluble components, in particular terpenes included in oil infusions, ointments, and creams.

Metabolism occurs in the liver with the participation of cytochrome P450 enzyme systems, glutathione transferases, and UDP-glucuronosyltransferases. Flavonoids and phenolic compounds undergo a conjugation phase — methylation, sulfation, and glucuronidation. These metabolites have lower biological activity but contribute to safe excretion. Glucosinolates, hydrolyzed by microflora, form isothiocyanates and thiocyanates, some of which undergo further oxidation in the liver.

Excretion of metabolites occurs primarily in the urine and bile. Polar flavonoid metabolites are excreted by the kidneys, while fat-soluble and isothiocyanate metabolites are excreted through the bile. With external use (ointment, cream, lotion, serum), accumulation of individual components in the stratum corneum of the epidermis with slow release is possible. Metabolism in this case is minimal, and excretion occurs through skin desquamation.

Features of pharmacokinetics with transdermal use include limited systemic absorption, which increases the safety profile for external forms. When using mucosal routes of administration (for example, in a cosmetic serum based on a water-soluble extract), rapid local absorption with minimal systemic distribution is noted.

The participation of intestinal microflora is critically important for the biotransformation of glycoside compounds and glucosinolates. Microbiota disorders can affect the bioavailability of active fractions, especially with long-term course administration. Metabolism in the liver does not lead to toxic metabolites and does not cause a significant load on the excretory organs when standard and preventive dosages are observed.

References:
https://pubmed.ncbi.nlm.nih.go...
https://www.sciencedirect.com/...
https://www.tandfonline.com/do...
https://www.ncbi.nlm.nih.gov/p...

Mechanisms of Action and Scientific Rationale — Barbarea vulgaris

The biological activity of Barbarea vulgaris is determined by the presence of a complex of secondary metabolites, including flavonoids, glucosinolates, saponins, and phenolic acids. The key mechanisms of action are considered to be the inhibition of inflammatory enzyme systems, modulation of cellular activation signaling cascades, antioxidant protection, and interaction with receptor structures of immune and neurohumoral regulation.

Flavonoids, represented by the aglycones kaempferol and quercetin, are able to reversibly bind to the active centers of the enzymes cyclooxygenase-2 (COX-2) and lipoxygenase (5-LOX), which leads to a decrease in the synthesis of pro-inflammatory mediators — prostaglandins and leukotrienes. These effects are accompanied by a decrease in the activation of innate immune cells, such as neutrophils and macrophages, and blocking of the transcription of pro-inflammatory cytokines through the NF-κB cascade.

One of the confirmed effects of the plant components is antioxidant activity, realized through direct neutralization of free radicals and induction of the expression of antioxidant enzymes, such as superoxide dismutase, glutathione peroxidase, and catalase. This contributes to the stabilization of mitochondrial membranes and a reduction in lipoperoxidation, especially under conditions of metabolic and oxidative stress.

Glucosinolates present in the aerial part of the plant, under the action of the enzyme myrosinase, are converted into isothiocyanates, which, according to experimental data, inhibit the activation of the MAPK and JAK/STAT cascade in immunocompetent cells. This leads to the regulation of interleukin production and suppression of inflammatory signal transduction that supports chronic activation of the immune system. Suppression of the expression of Toll-like receptors on the surface of macrophages has also been noted, which additionally reduces sensitivity to inflammatory signals.

Saponins and bitters in the composition of Barbarea vulgaris modulate the autonomic link of regulation through parasympathetic stimulation, which is manifested in increased secretion of the digestive glands and motility of the gastrointestinal tract. These effects are presumably mediated through activation of muscarinic receptors and modulation of the acetylcholine cascade, as well as local effects on the smooth muscles of the intestinal wall.

In skin tissues, oil and aqueous extracts of the plant exhibit dermatotropic activity through inhibition of the growth of a number of bacterial and fungal pathogens. In vitro studies have shown that phenolic compounds and isothiocyanates disrupt the integrity of the cell wall of microorganisms, contributing to their lysis and a reduction in colonization of the surface epidermis.

A number of studies have also shown that kaempferol and its glycosides have a mild anxiolytic effect due to partial inhibition of the enzyme monoamine oxidase A (MAO-A) and potentiation of the neurotransmitter response. This is manifested through an increase in the levels of serotonin and dopamine in the central nervous system and may be associated with mild regulation of neurovegetative tone.

Thus, the biological effects of Barbarea vulgaris are due to the complex effect on the enzyme systems of inflammation and oxidative stress, signaling molecules of innate immunity, receptor structures of nervous regulation, and membrane mechanisms of microorganisms.

References:
https://pubmed.ncbi.nlm.nih.go...
https://www.sciencedirect.com/...
https://www.tandfonline.com/do...
https://www.ncbi.nlm.nih.gov/p...
https://pubmed.ncbi.nlm.nih.go...

Synergy — Barbarea vulgaris

Pharmacological synergy of Barbarea vulgaris has been confirmed in a number of preclinical and experimental studies that evaluated the interaction of plant extracts with other natural and synthetic substances. The most pronounced synergistic effect is observed when combining Barbarea components with polyphenolic flavonoid substances, adaptogens, and hepatoprotectors that have similar or complementary mechanisms of action.

It has been documented that the combination of Barbarea vulgaris extract with compounds containing quercetin, rutin, and luteolin enhances antioxidant activity through additive suppression of lipid peroxidation and increased resistance of cell membranes. The combined action of flavonoids enhances the expression of endogenous antioxidant enzymes and increases the activity of the glutathione system. Such a combination demonstrates tissue-specific targeting, mainly in relation to parenchymal organs, especially the liver.

A potentiating anti-inflammatory effect is noted with the combined use of Barbarea vulgaris extracts with curcuminoid derivatives and compounds based on boswellic acids. These substances complement the action of glucosinolates and phenolic acids of Barbarea, jointly inhibiting COX-2 and 5-LOX enzymes, as well as reducing the expression of pro-inflammatory cytokines. This leads to suppression of the activity of the NF-κB signaling pathway and stabilization of the cellular response in tissues with a high inflammatory index.

The modulating effect on the immune system is enhanced when combining Barbarea vulgaris with plants containing β-glucans, arabinogalactans, and other immunomodulating polysaccharides. In an in vivo model, it was established that such interaction contributes to the stimulation of phagocytosis, normalization of T-helper activity, and reduction of hyperproduction of pro-inflammatory mediators. The effect is systemic in nature and is manifested in a balanced effect on the cellular and humoral components of immune regulation.

Barbarea also demonstrates synergistic interaction with adaptogen components, such as phenolic glycosides and terpenoids, through modulation of MAPK signaling pathways and increased cell resistance to oxidative and metabolic stresses. This interaction is manifested in improved adaptation reactions, stabilization of the endocrine profile, and normalization of autonomic nervous system reactivity.

The topical combination of Barbarea vulgaris extracts with essential oils of tea tree, lavender, and rosemary demonstrates potentiation of antiseptic activity and inhibition of the growth of dermatotropic pathogens. This is explained by the combined effect on the bacterial membrane, disruption of energy metabolism in the cell, and inhibition of biofilms.

Finally, in transdermal and cosmetic forms, a protective effect has been recorded when combined with natural lipids (jojoba oil, grape seed oil), due to stabilization of the skin barrier, restoration of the lipid matrix, and increased penetrating ability of water-soluble components.

References:
https://pubmed.ncbi.nlm.nih.go...
https://www.sciencedirect.com/...
https://www.ncbi.nlm.nih.gov/p...
https://www.tandfonline.com/do...
https://pubmed.ncbi.nlm.nih.go...

Geography of Use and Traditional Medicine — Barbarea vulgaris

Barbarea vulgaris has been traditionally used in the folk medicine and food practices of Europe, the Middle East, and Central Asia, as well as in certain regions of Southeast Asia. The plant is most widespread in the ethnobotanical traditions of Germany, the Czech Republic, Poland, Ukraine, the Caucasus, Iran, Uzbekistan, and western China, where it is known under various names associated with the concepts of "mustard," "wild cress," and "yellow rocket."

In the Slavic herbalist tradition, fresh leaves and juice of Barbarea were used externally in the form of compresses and lotions, especially in the spring period. It was believed that the plant has the ability to "dispel spring ailments," cleansing the skin and stimulating "bile outflow." The aerial part was used to prepare decoctions and lotions that were applied to the face, hands, and back. Dried inflorescences were included in so-called "bitter collections" — mixtures intended to cleanse the body of "internal mucus." In West Russian and Belarusian herbal books, Barbarea was also called "herb of purity" and "herb for liver sorrow."

In the Caucasian ethnomedical tradition, the plant was used as a remedy for rubbing and wraps, especially in the spring period, when it was believed that the body was weakened and needed restoration. Both fresh leaves and vinegar infusions were used, which were applied to the body before a bath. Among Georgian and Armenian herbalists, the practice of adding the plant to cleansing herbal collections with bitters is recorded.

In the Middle East and Persia, Barbarea was included in traditional spring dishes and infusions used as a cleansing remedy. In Iranian and Kurdish villages, it is still sometimes called the "green healer of spring." Its use is also described in the form of cold water infusions and green pastes for application to the temples and neck.

In the Islamic medical tradition of Central Asia, especially in Uzbek, Tajik, and Kazakh sources, the plant was included in cleansing collections used before fasting or during seasonal transitions. In some cases, fresh shoots were chewed on an empty stomach as a remedy "for heaviness in the right side."

In Eastern Europe, Barbarea vulgaris in ritual practice was associated with purification rites of the spring equinox. It was believed that its bitter juice helps to "remove melancholy and winter darkness." In folklore, there are references to the use of wreaths and sheaves of Barbarea to protect the home from "evil spirits of spring revelry," especially in Lithuania and Latvia.

In Chinese tradition, the plant is found in local phytotherapeutic practices of Yunnan province, where it is used as a seasonal vegetable and is included in bitter teas. Although it is not included in the canonical treatises of traditional Chinese medicine, references to it are recorded in regional herbal books as a remedy used by women in the postpartum period for wraps and skin cleansing.

In ethnographic records of France and Brittany, the practice of rubbing joints with Barbarea juice before sleep is mentioned, "to expel cold and dampness from the body." Cases of smoking dried leaves for therapeutic and ritual purposes among Old Believer communities of northern Europe, especially during the Easter fast, have also been described.

Thus, Barbarea vulgaris has a wide geography of ethnomedical use with a predominance of spring and cleansing functions. Its use covers internal and external forms, including decoctions, infusions, compresses, wraps, and ritual wreaths, which confirms its stable place in the folk culture and folklore-medical systems of Eurasia.